Skip to main content
Journal cover image

Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders.

Publication ,  Journal Article
Fuchs, M; Monto, A; Bräu, N; Charafeddine, M; Schmidt, W; Kozal, M; Naggie, S; Cheung, R; Schnell, G; Yu, Y; Richards, K; Mullally, V ...
Published in: J Med Virol
December 2020

Hepatitis C virus (HCV) infections are more common among US veterans receiving care through Veterans Affairs (VA) Medical Centers than among the general population. Historically, HCV therapies had lower efficacy rates in VA patients, possibly due to common comorbidities such as psychiatric disorders and substance abuse. The direct-acting antivirals ombitasvir/paritaprevir/ritonavir and dasabuvir (OBV/PTV/r+DSV)±ribavirin (RBV) are approved in the US for HCV genotype 1 (GT1)-infected adults with or without cirrhosis. This study prospectively evaluated the safety and efficacy of OBV/PTV/r+DSV±RBV in VA patients with HCV GT1 infection. TOPAZ-VA was a phase 3b, open-label trial. Adult US veterans with HCV GT1 infection, without cirrhosis or with compensated cirrhosis, were eligible for enrollment. Patients with GT1a infection received OBV/PTV/r +DSV+RBV for 12 weeks or 24 weeks (for those with cirrhosis); GT1b-infected patients without cirrhosis received OBV/PTV/r +DSV for 12 weeks; those with cirrhosis received OBV/PTV/r +DSV with RBV. The primary endpoint was sustained virologic response at posttreatment week 12 (SVR12); safety was also assessed. Ninety-nine patients were enrolled at 10 sites from May through November 2015. The majority were male (96%), white (60%), and with GT1a infection (68%); 49% reported ongoing psychiatric disorders. Overall, 94% (93/99) achieved SVR12; three patients had a virologic failure. The most common AEs were fatigue (28%), headache (20%), and nausea (15%); six patients discontinued treatment due to AEs. In US veterans with HCV GT1 infection, OBV/PTV/r +DSV±RBV yielded a 94% overall SVR12 rate and was well tolerated. The presence of psychiatric disorders and/or injection drug use did not impact efficacy.

Duke Scholars

Published In

J Med Virol

DOI

EISSN

1096-9071

Publication Date

December 2020

Volume

92

Issue

12

Start / End Page

3459 / 3464

Location

United States

Related Subject Headings

  • Virology
  • 3207 Medical microbiology
  • 3202 Clinical sciences
  • 3107 Microbiology
  • 1108 Medical Microbiology
  • 0605 Microbiology
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Fuchs, M., Monto, A., Bräu, N., Charafeddine, M., Schmidt, W., Kozal, M., … Toro, D. (2020). Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders. J Med Virol, 92(12), 3459–3464. https://doi.org/10.1002/jmv.25655
Fuchs, Michael, Alexander Monto, Norbert Bräu, Mariem Charafeddine, Warren Schmidt, Michael Kozal, Susanna Naggie, et al. “Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders.J Med Virol 92, no. 12 (December 2020): 3459–64. https://doi.org/10.1002/jmv.25655.
Fuchs M, Monto A, Bräu N, Charafeddine M, Schmidt W, Kozal M, et al. Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders. J Med Virol. 2020 Dec;92(12):3459–64.
Fuchs, Michael, et al. “Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders.J Med Virol, vol. 92, no. 12, Dec. 2020, pp. 3459–64. Pubmed, doi:10.1002/jmv.25655.
Fuchs M, Monto A, Bräu N, Charafeddine M, Schmidt W, Kozal M, Naggie S, Cheung R, Schnell G, Yu Y, Richards K, Mullally V, Cohen DE, Toro D. Ombitasvir/paritaprevir/ritonavir and dasabuvir±ribavirin for chronic HCV infection in US veterans with psychiatric disorders. J Med Virol. 2020 Dec;92(12):3459–3464.
Journal cover image

Published In

J Med Virol

DOI

EISSN

1096-9071

Publication Date

December 2020

Volume

92

Issue

12

Start / End Page

3459 / 3464

Location

United States

Related Subject Headings

  • Virology
  • 3207 Medical microbiology
  • 3202 Clinical sciences
  • 3107 Microbiology
  • 1108 Medical Microbiology
  • 0605 Microbiology